Viewing Study NCT01242228


Ignite Creation Date: 2025-12-26 @ 10:33 AM
Ignite Modification Date: 2025-12-29 @ 10:38 AM
Study NCT ID: NCT01242228
Status: COMPLETED
Last Update Posted: 2025-05-30
First Post: 2010-11-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients
Sponsor: Astellas Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module